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Background:  Left ventricular (LV) wall thickness is a prognostic marker in hypertrophic cardiomyopathy (HCM). Specifically, prior 
investigations have demonstrated that LV wall thickness ≥ 30 mm (massive hypertrophy) is independently associated with sudden 
cardiac death. The presence of massive hypertrophy is used to guide implantable cardiac defibrillator decision-making. We sought to 
determine whether measures of maximal LV wall thickness differ between cardiac magnetic resonance imaging (MRI) and transthoracic 
echocardiography (TTE).
methods:  Consecutive patients with HCM without prior septal ablation or myectomy who underwent both cardiac MRI and TTE at a single 
tertiary referral center were retrospectively included in an IRB approved protocol. Reported maximal LV wall thickness was recorded and 
compared between the two imaging modalities. The difference between reported LV wall thicknesses was assessed with respect to age, 
gender, body habitus, and morphology of septal hypertrophy. Furthermore, a subset analysis of the 63 patients with at least one modality 
reporting a wall thickness ≥ 30 mm was performed.
results:  There were 620 patients with a median age of 53 years including 381 (61%) men. In 76 (12%) patients the reported maximal LV 
wall thickness was identical between MRI and TTE. The mean difference in reported maximal LV wall thickness measurement between 
the modalities was 3.3 mm, with a maximum difference of 17 mm. This difference was consistent regardless of age, body habitus or HCM 
subtype. Of the 63 patients with at least one modality measuring a maximal LV wall thickness ≥ 30 mm, 44 patients (70%) had discrepant 
classification with regards to presence of massive hypertrophy. MRI identified 52 (83%) of patients with massive hypertrophy whereas TTE 
identified 30 (48%) patients.
conclusion:  Current guidelines recognize that both MRI and TTE imaging are integral in assessing cardiac anatomy in HCM. However, 
the current study reveals a discrepancy between these modalities for maximal LV wall thickness assessment. Therefore, multi-modality 
imaging is necessary to adequately characterize key clinical decision-informing features in HCM.
